- Home
- SHOT vs RLYB Comparison
SHOT vs RLYB Comparison
Compare SHOT & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- RLYB
- Stock Information
- Founded
- SHOT 2018
- RLYB 2018
- Country
- SHOT United States
- RLYB United States
- Employees
- SHOT N/A
- RLYB N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- RLYB Health Care
- Exchange
- SHOT Nasdaq
- RLYB Nasdaq
- Market Cap
- SHOT 49.9M
- RLYB 46.1M
- IPO Year
- SHOT 2020
- RLYB 2021
- Fundamental
- Price
- SHOT $1.32
- RLYB $1.14
- Analyst Decision
- SHOT
- RLYB Buy
- Analyst Count
- SHOT 0
- RLYB 6
- Target Price
- SHOT N/A
- RLYB $8.30
- AVG Volume (30 Days)
- SHOT 810.2K
- RLYB 50.0K
- Earning Date
- SHOT 11-14-2024
- RLYB 11-07-2024
- Dividend Yield
- SHOT N/A
- RLYB N/A
- EPS Growth
- SHOT N/A
- RLYB N/A
- EPS
- SHOT N/A
- RLYB N/A
- Revenue
- SHOT $1,025,549.00
- RLYB $299,000.00
- Revenue This Year
- SHOT N/A
- RLYB N/A
- Revenue Next Year
- SHOT N/A
- RLYB N/A
- P/E Ratio
- SHOT N/A
- RLYB N/A
- Revenue Growth
- SHOT 68.01
- RLYB N/A
- 52 Week Low
- SHOT $0.55
- RLYB $1.08
- 52 Week High
- SHOT $7.50
- RLYB $4.60
- Technical
- Relative Strength Index (RSI)
- SHOT 58.88
- RLYB 52.74
- Support Level
- SHOT $1.11
- RLYB $1.09
- Resistance Level
- SHOT $1.34
- RLYB $1.18
- Average True Range (ATR)
- SHOT 0.15
- RLYB 0.04
- MACD
- SHOT -0.01
- RLYB 0.01
- Stochastic Oscillator
- SHOT 39.18
- RLYB 55.56
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.